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In vivo fusion cleavageEukaryotic membrane protein expression is still a major bottleneck for structural studies. Production in E. coli
often leads to lowexpression level and/or aggregatedproteins. In the last decade, strategies relying onnew fusion
protein expression revealed promising results. Fusion with the amphipatic Mistic protein has been described to
favor expression in E. colimembranes. Although, this approach has already been reported for a few membrane
proteins, little is known about the activity of the fused proteins. We used this strategy and obtained high
expression levels of a chloroplast ATP/ADP transporter from A. thaliana (NTT1) and characterized its transport
properties.NTT1 fused toMistichas a very low transport activitywhich canbe recoveredafter in vivoMistic fusion
cleavage. Moreover, detailed molecular characterization of puriﬁed NTT1 mature form, NTT1 fused to Mistic or
NTT1 cleaved-off from this fusion highlights the correct fold of the latter one. Therefore, considering the higher
quantity of puriﬁed NTT1 mature form obtained via the Mistic fusion approach, this is a valuable strategy for
obtaining quantities of pure and active proteins that are adequate for structural studies.turale, 41 Rue Jules Horowitz,
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Although 20 to 30% of the genomes code for membrane proteins [1],
the latter represent less than1%of the structures deposited in thePDB [2].
Membraneproteins control all the signaling andexchanges between cells
and intracellular compartments and are therefore key elements in most
biological processes. Indeed, 60 to 70% of drugs target membrane
proteins. The discrepancy between their relevance and the lack of
structural information lies in the difﬁculties to handle such amphipatic
molecules. It is well known that their overexpression into themembrane
of host cells is often highly poisonous. Solubilization of the produced
proteins in a stable and functional conformation is a second major
bottleneck. This process requires exploring various amphiphiles, includ-
ing lipids, and characterizing the protein-detergent complex using acombination of complementary biochemical and biophysical techniques,
none of them being sufﬁcient on its own. Finally, crystallization still
remains a difﬁcult step although novel methods based on lipidic phases
and developed over the last 15 years have opened new ways of
investigations [3–5]. The success rate of crystallization strongly relates
to the quality of the previous steps: protein expression and solubilization.
Because of the importance of membrane proteins, several teams have in
the last decade extensively explored various expression systems [6,7].
Therefore, the best strategy to crystallize a new protein remains to
explore these methods in parallel.
In a recentmedium-scale approach aiming to overexpressmembrane
proteins, 17 different intrinsic membrane proteins have been tested
for expression in six expression systems. Among those, the recently
described Mistic fusion approach has been successfully tested. Indeed,
for any of the 12 membrane proteins effectively expressed in E. coli, the
Mistic fusion has always led to increased expression levels. Furthermore,
in some cases Mistic fusion delivered protein amounts compatible
with structural studies. However, the number of publications related to
this Mistic fusion approach and describing integral membrane protein
overexpression remains low [8–13] and the membrane integration
mechanism of Mistic is still elusive. Previous publications mainly
report about expression levels and some biochemical or biophysical
2060 A. Deniaud et al. / Biochimica et Biophysica Acta 1808 (2011) 2059–2066characterizations but only a fewof themdescribe functional properties of
the overexpressed proteins [10,13]. So far no functional validation has
been performed for a membrane transporter fused to Mistic. Bacterio-
rhodopsin is the only membrane protein with several trans-membrane
helices for which functional assays have been reported [10].
The present study focuses on the chloroplast ATP/ADP transporter
from Arabidopsis thaliana (NTT1) [14,15], one of the 17 membrane
proteins previously studied. NTT1 is a 60 kDa transporter located in
the inner membrane of the chloroplast envelope that exchanges ATP
with ADP [14,16]. Eleven to twelve trans-membrane helices are
predicted from its primary sequence. Asmost chloroplast proteins, the
NTT1 N-terminus (chloroplast targeting sequence) is cleaved-off
during its integration into the chloroplast envelope membrane. After
cleavage, the mature form of the protein is folded and turns into a
functional transporter [14,15]. In the late nineties, it has been shown
that it was possible to express this transporter in a functional form in
E. coli membranes [14]. Further functional characterization led to the
discovery of charged residues crucial for steady-state ATP/ADP
exchange [17]. More recently, studies have focused on bacterial
homologues of NTT1 [16,18] providing a general model for transport
of both bacterial and plastidial ATP/ADP transporters. It has thus been
proposed that these proteins transport ADP+Pi against ATP in a
counter-exchange way [16]. These recent reports provided the ﬁrst
puriﬁcation procedure of NTT1s expressed in bacteria [16,18]. Our
medium-scale overexpression approach conﬁrmed that A. thaliana
NTT1 can be well expressed in E. coli but also indicated that, when
fused to Mistic, NTT1 can be expressed at higher level. We previously
reported that NTT1 is expressed as an active transporter in L. lactis but
at a lower yield [19]. We herein further explored the production of
NTT1 in E. coli and compared the activity of both proteins, the mature
form of NTT1 and NTT1 bearing a N-terminal Mistic fusion (misNTT1).
Differences in functional properties are evidenced. They are charac-
terized and discussed in light of different constructs and biochemical
and biophysical approaches.
2. Material and methods
2.1. Materials
Detergents were obtained from Anatrace, all other chemicals from
Sigma.
2.2. Molecular cloning and DNA manipulation
The different constructs used are depicted in Fig. S1 and the
primers used for their generation are listed in the Table S1. NTT1
UniProt sequence number Q39002 lacking the ﬁrst 79 residues
composing the N-terminal leader peptide has been used for further
cloning. NTT1 has been cloned by the Gateway technology (Invitro-
gen) into pDEST17 (Invitrogen) and misNTT1 into pDEST-Mistic.
Thus, schematically the NTT1 expressed sequence is MSYY-HHHHHH-
LE-AttB1site -NTT1seq-Streptag and the misNTT1 expressed sequence
is MSYY-HHHHHH-LE-Mistic-LE-AttB1site-NTT1seq-Streptag. Amino
acid sequences of all linkers are described in Table S1. misTmNTT1
has also been cloned by the Gateway technology using a modiﬁed
pDEST-Mistic vector containing an insert between the ORF of Mistic
and the AttB1 site. This insert yields an additional transmembrane
domain sequence in the misTm construct (see Table S1). The longer
linker in mislinkNTT1 and the TEV and the factor Xa cleavage sites
have been introduced in the misNTT1 construct using the Quick
Change Site Directed Mutagenesis kit from Agilent Technologies with
the primers mislinkNTT1for, mislinkNTT1rev, misTevNTT1for, mis-
TevNTT1rev, misXaNTT1for and misXaNTT1rev (Table S1). The linker
of mislink sequence is described in the Table S1. The tetracycline-
inducible TEV plasmid has been generated in a two-step PCR [20]. The
ﬁrst PCR was done with Pfu polymerase (New England Biolabs) toamplify MBP-TEV coding cDNA using the primers pTEVfor and
pTEVrev. The puriﬁed PCR product was then used as primers in a
Quick Change PCR (Agilent) with pG-KJE6 as matrix in order to insert
MBP-TEV into the pG-KJE6 [21].
2.3. Expression and puriﬁcation
The different constructs were expressed in C43(DE3) cells [22].
Freshly transformed cells were grown in TB medium at 37 °C until
OD600nm=0.6 was reached. Then, protein overexpression was
induced by addition of 0.5 mM IPTG and overnight growth at 20 °C.
For the expression of the in-membrane cleaved form of misTevNTT1,
the protein was always expressed overnight. The TEV protease (TEV)
was induced by the addition of 20 ng/mL tetracycline either at the
same time as misTevNTT1 or after the overnight expression to have a
sequential expression, misTevNTT1 then TEV. In the latter case, TEV
was expressed for 3 h. All bacterial cultures were stopped after this
3 h TEV induction. Overexpressed proteins have been quantiﬁed by
Strep-Tactin peroxidase (IBA) or anti-histag peroxidase (Sigma)
western-blots with standard proteins.
For membrane preparation, cell pellets were resuspended in
100 mM Tris pH 8, 500 mM NaCl, 1 mM MgCl2, DNAse and complete
protease inhibitors 1 pill/50 mL (Roche). Cells were disrupted by two
passages through a microﬂuidizer cell at 180 psi (Microﬂuidics).
Unbroken cells were removed by centrifugation at 10,000×g for
15 min and then membranes were sedimented at 150,000×g for
90 min. Finally, these membranes were resuspended at 20 mg/mL in
100 mM Tris pH 8, 500 mM NaCl and stored at −80 °C.
For protein puriﬁcation, membranes were solubilized in 50 mM Tris
pH 8, 100 mM NaCl, 1% (w:v) LAPAO, 10 mM imidazole, EDTA-free
complete protease inhibitors 1 pill/50 mL (Roche) for 1 h at 4 °C with
constant mixing. Unsolubilized membranes were removed by centrifu-
gation at 100,000×g for 1 h at 4 °C. Then the supernatant was incubated
with Ni-NTA beads (Qiagen) for 2 h at 4 °C with constant stirring. The
resin was then washed with 20 mM Tris pH 8, 100 mMNaCl, 0.1% (w:v)
LAPAO containing 10 mM imidazole in aﬁrstwash and 20 mM imidazole
in a second wash. Proteins were eluted from Ni-NTA beads using the
samebuffer containing 200 mM imidazole. Bufferwas exchanged using a
PD10 column (GE-healthcare) to 20 mM Tris pH 8, 100 mM NaCl, 0.1%
(w:v) LAPAO, just before mixing with Strep-Tactin beads (IBA). The
mixturewas incubatedovernightwith constant stirring at 4 °C. Thebeads
were extensively washed with the PD10 buffer and the ﬁnal elution was
performed in the same buffer containing 3 mM desthiobiotin (IBA).
Further buffer exchangewas performed using a PD10 column in order to
remove desthiobiotin. For clmisXaNTT1 puriﬁcation, the fusion was
cleaved between the Ni-NTA and the Strep-Tactin chromatography steps
by an overnight incubation of the Ni-NTA eluted proteins with factor Xa
using 1 unit of protease for 50 μg of proteins.When required, the puriﬁed
proteins were concentrated on an Amicon concentrator with a 50 kDa
cut-off. Size exclusion chromatography (SEC) experiments were per-
formed on a 20 mL analytical superdex-200 in 20 mMTris pH 8, 100 mM
NaCl, 0.1% (w:v) LAPAO at a 0.4 mL/min ﬂow rate.
2.4. Activity measurements
Activities were measured on whole E. coli cells in conditions
similar to those described in [23,24]. Brieﬂy, after protein over-
expression, cells were washed and resuspended in 50 mM phosphate
buffer pH 7.5. For radioactivity experiments, 30 μL of cells at 100 μg/μL
were incubated with radioactive ATP (3000 mCi/mmol, Perkin Elmer)
at 25 °C for indicated time periods. ATP uptake was quenched by
addition of 1 mL ice-cold phosphate buffer, subsequently ﬁltered
through a 0.45 μm ﬁlter (Millipore) and washed three times with
1 mL of phosphate buffer. The radioactivity retained on the ﬁlters was
quantiﬁed in 3.5 mL of water in a Multi-Purpose Scintillation Counter
(Beckman Coulter, Fullerton, USA). For luminescence experiments
Fig. 1. NTT1 and misNTT1 expressions in various E. coli strains. NTT1 and misNTT1 total
expression after overnight induction in different strains: BL21(DE3), Rosetta2(DE3)
(Ros2), C41(DE3), C43(DE3). Overexpressed proteins were detected by Strep-Tactin
peroxidase western-blots. NTT1 is observed around the 50 kDa marker and misNTT1
around the 72 kDa marker. For NTT1 1 mg of bacteria have been loaded per lane and for
misNTT1500 μg. * indicates the biotin carboxyl carrier protein (BCCP), an endogenously
biotinylated protein always detected by Strep-Tactin peroxidase in whole bacterial
extracts. MM corresponds to the molecular weight marker lanes.
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containing 40 μM luciferin (Sigma) and 40 μg/mL luciferase (Sigma) in
a 1-mL cuvette and the luminescence was monitored. When the
baseline is stable, the desired ADP concentration is added to the
cuvette and the luminescence is monitored during 5 min. For all
activity experiments, whole cell proteins were separated by SDS-
PAGE and transferred onto nitrocellulose membrane. The different
NTT1 constructs were then detected with anti-Histag peroxidase or
Strep-Tactin peroxidase conjugates, depending on the construct used.
Western-blots were revealed on a Kodak 4000MM image station and
quantiﬁcation was done with the Molecular Imaging Software
(Kodak) using different concentrations of pure NTT1 and misNTT1
as standards. VM and KM determinations have been performed with
the software KaleidaGraph by using Michaelis–Menten equation to ﬁt
the experimental data.
2.5. Limited proteolysis
Limited proteolysis experiments were performed on pure proteins
in LAPAO as previously described in [25].
2.6. Analytical centrifugation
The experiments were performed using a Beckman XL-I analytical
ultracentrifuge and an An-60Ti rotor (Beckman Coulter) in 12 mm
or 3 mm optical path length cell equipped with sapphire windows.
Sample density and viscosity were 1.004 g/mL and 1.32 mPa.s,
respectively. 280 nm absorbance proﬁles were measured during 16 h
at 42,000 rpmand 10 °C. Analysiswas done in terms of continuous size-Table 1
Comparison of the expression yield and activity of NTT1 and the different NTT1 mistic fusio








mislinkNTT1 0.06 6.6distribution (c(s)) with the Sedﬁt program [26], considering 200
particles with sedimentation coefﬁcients, s, between 0.1 and 20 S,
with a frictional ratio of 1.25 and a partial speciﬁc volume of 0.89 mL/g,
and applying regularization procedure with a conﬁdence level of 0.68.
3. Results and discussion
3.1. Mistic fusion enhances the expression level but alters NTT1 activity
3.1.1. Protein expression
The different constructs used in this study are presented in Fig. S1.
Initial expression tests showed that in our experimental conditions,
NTT1 andmisNTT1were not expressed in Rosetta2 cells (Fig. 1)which is
in opposition fromwhat has recently been described [16]. For bothNTT1
andmisNTT1 expressionwas weak in BL21(DE3) and C41(DE3) (Fig. 1),
but on the other hand, the expression level was high in C43(DE3) cells
[22] with misNTT1 leading to quite higher protein amounts (Fig. 1).
These results are consistent with two previously published concepts.
Firstly,membraneproteins are usuallywell expressed inC43cells,which
is probably due to their ability toproduceextra internalmembranes [27].
Secondly, Mistic fusion has been proposed to pull membrane protein
into the lipid bilayer independently of the Sec translocon. Therefore,
misNTT1 expression into themembranewas greatly enhanced thanks to
C43 cells and Mistic. Thus, overnight expression at 20 °C led to overall
expression levels of about 2.5 mg- and 40mg-/L of culture for NTT1 and
misNTT1, respectively (Table 1). This 16 fold increase for misNTT1
expression level is promising, but its quality (folding and activity) has to
be ascertained prior to structural studies.
3.1.2. Import and export of ATP
Transport measurements have been performed onwhole E. coli cells,
before solubilizing themembranes and purifying the proteins. Thus, the
functional properties of the overexpressed proteins were assessed
directly in the E. colimembrane prior to any modiﬁcations of their local
environment. Transport activities have beenmeasured by two indepen-
dent methods: radioactive ATP uptake and cold ADP/ATP exchange
followed by luminescence. The latter assay has been established in our
team on the basis of previous experiments performed on puriﬁed
mitochondria [28]. In this assay, addition of ADP induces a simultaneous
and continuous ATP export from intact E. coli cells (Fig. 2A), which is
monitored by the luminescence resulting from a luciferin/luciferasemix
present in theexternal buffer (Fig. 2A). Thismethod is complementary to
radioactive ATP uptake measurements since it monitors the nucleotide
transport in the opposite direction (export from E. coli versus import).
Moreover, this assay also allows the monitoring of nucleotide exchange
in real time and not just the determination of a net nucleotide import or
export. This method is highly sensitive and speciﬁc as seen from
the signiﬁcant light emission obtained with NTT1 (Fig. 2A, NTT1 curve),
in comparison to the ﬂat curve obtained with bacteria containing
an empty vector (Fig. 2A, ctl curve). The luminescence assay showed
that the global release of ATP was very high and long-lasting in
bacteria overexpressing NTT1 (Fig. 2A, NTT1 curve). On the contrary,
cells overexpressing misNTT1 displayed an initial light increase smaller
than for NTT1 expressing cells (Fig. 2A, ﬁrst seconds after ADP addition)ns. Expression yields of the different constructs have been determined by western-blot











Fig. 2. Transport activity of NTT1 and misNTT1 fusions. Panel A, luminescence measurements for NTT1, misNTT1 expressing cells and background control (ctl) for an empty vector-
containing cells. Panel B, speciﬁc radioactive ATP uptake kinetics for NTT1 and misNTT1 expressing cells in nmole of ATP per mg of NTT1 or misNTT1. Proteins were quantiﬁed by
western-blot. These experiments have been performed using 50 μM ATP and for each curve the background uptake has ﬁrst been subtracted. Panel C, 15 min time-point for NTT1,
misNTT1, misTmNTT1 and mislinkNTT1 speciﬁc radioactive ATP uptake using 50 μM ATP comparison with NTT1 uptake deﬁned as 100% level. Mean of three independent
experiments. Amount of ATP imported per mg of NTT1 proteins is indicated into brackets. Panel D, NTT1 and misNTT1 VMKM experiments. Experimental points are shown with
markers and ﬁts shown with lines. For panels A, B and D one representative experiment is shown from a set of at least three independent experiments.
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fact that luciferase light emission is transient anddepends on continuous
supplyof newATPmolecules. ThusmisNTT1exhibiteda slowerADP/ATP
transport activity than NTT1 (Fig. 2A).
In parallel, radioactive ATP uptake into E. coli cells overexpressing
NTT1 or misNTT1 showed that the speciﬁc activity of misNTT1 was
5 to 10 times lower than that of NTT1 at 50 μM of ATP (Fig. 2B–C).
3.1.3. Transport rates
To compare in details the transport properties of NTT1 and
misNTT1, VM and KM parameters were determined from radioactive
ATP uptake assays. Regarding the high activity of NTT1 produced in
E. coli, these velocity experiments were very robust and Michaelis–
Menten equation ﬁtted very well the experimental data (Fig. 2D and
Table 1). On the contrary, the low transport activity of misNTT1 led to
data with higher standard deviations (Fig. 2D and Table 1). NTT1 and
misNTT1 KM values for ATP were in the same range: 32 μM and 40 μM,
respectively, but the misNTT1 VM value was 10 times lower than that
of NTT1 (Table 1). The KM for ADP was determined through the
luciferase assay in order to characterize the behavior with this
nucleotide (Table 1). NTT1 and misNTT1 KM values were 7 μM and
19 μM, respectively, in good agreement with a previously published
value determined for NTT1 (12 μM) using radioactive ADP uptake
measurements [29]. Therefore, while KM values for ADP and ATP were
in the same range, VM values strongly differed for NTT1 and misNTT1.
3.2. Can the activity of misNTT1 be recovered?
3.2.1. The orientation of misNTT1 in the membrane is not responsible for
its lower activity
One explanation for the lower activity of misNTT1, when
compared to the one of NTT1, might result from an invertedintegration of the Mistic fusion in E. coli membranes. A new Mistic
fusion (termed misTmNTT1, see Fig. S1 and Table S1) has been
constructed, containing one additional transmembrane α-helix at
the C-terminus of Mistic in order to invert the orientation of the
fused membrane protein across the bacterial membrane. Indeed,
in misNTT1 the short linker between Mistic and NTT1 obligates the
C-terminus of Mistic and the N-terminus of NTT1 to be on the same
side of the membrane. Whether this orientation of NTT1 is
appropriate for its function is not known. Although the N-terminus
of NTT1 in misTmNTT1 should now be located at the opposite side of
the membrane, the same low transport activity was observed (Fig. 2C
and Table 1).
3.2.2. Mistic does not hinder the transport by conformational constraints
The lower activity of misNTT1 might also result from conforma-
tional constrains within the Mistic fusion. Indeed, a too short linker
between Mistic and NTT1, could hinder conformational changes that
are often necessary for transport mechanisms of molecules as large as
nucleotides. To test such a hypothesis, a longer linker between Mistic
and NTT1 (mislinkNTT1, Fig. S1 and Table S1) has been engineered in
order to get rid of a potential locking effect due to the fusion. The
linker has been enlarged from 10 to 25 residues and composedmainly
of G, S, N and L in order to be rather hydrophilic and to increase its
ﬂexibility. However, the activity of mislinkNTT1 was similar to the
ones of the other Mistic fusions tested (Fig. 2C and Table 1).
Furthermore, the expression yields of the different Mistic fusions
were quite similar with the exception of mislinkNTT1, which was
almost not expressed (Table 1). Thus, the low activity of those fusions
is neither due to a saturation problem of any machinery, nor to an
impairing of the dynamical properties of the membrane. Two points
that could both result from a high level of membrane protein
overexpression, which was not the case for mislinkNTT1.
Fig. 4. NTT1, misXaNTT1 and cleaved misXaNTT1 puriﬁcation. Assessment of the ﬁnal
purity of NTT1, misXaNTT1 and clmisXaNTT1 on Coomassie-stained 10% acrylamide
SDS-PAGE. 5 μg of each protein have been loaded. MM corresponds to the molecular
weight marker lanes.
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In order to test whether the NTT1 moiety is correctly folded in the
misNTT1 fusion, an in vivo fusion cleavage strategywas developed. For
in vivo proteolysis of the fusion, a TEV cleavage site has been
introduced into misNTT1 to generate misTevNTT1 (Fig. S1). The
expression level and the activity of misTevNTT1 were similar to those
of misNTT1 (not shown). A tetracycline-inducible plasmid, allowing
the expression of a TEV protease active form in vivo has been
constructed (Fig. 3A, Histag panel). In bacterial cells containing both
plasmids Mistic was efﬁciently cleaved-off from misTevNTT1 located
in the bacterial membrane by the TEV protease (Fig. 3A). Indeed,
this co-expression led to the detection of both NTT1 mature form
(via Streptag detection, Fig. 3A, Streptag panel) and Mistic alone
(15 kDa, via Histag detection, Fig. 3A, Histag panel). Although this
tetracycline-inducible expression system is tighter than others,
promoter expression leaks have anyhow been observed, particularly
in C43(DE3) cells. Therefore, BL21(DE3) cells have been selected
as an alternative for these experiments. The transport activity has
been followed by radioactive ATP uptake in cells expressing either
TEV protease or misTevNTT1 only, as well as in cells co-expressing
misTevNTT1 and TEV, either simultaneously or sequentially (ﬁrst
misTevNTT1, then TEV) (Fig. 3B). When compared to misTevNTT1
alone, the speciﬁc ATP uptake was increased three times when both
misTevNTT1 and TEV were expressed simultaneously and four-fold
when the two proteins were expressed sequentially. This last result
clearly highlights the recovery of NTT1's activity after cleavage, once
the Mistic fusion was already inserted into the membrane.
In conclusion about transport activities, all of the Mistic-NTT1
fusion proteins were considerably slowed down in comparison to
NTT1's mature form. As evidenced by the transport measurements
performed on four different constructs (NTT1, misNTT1, misTmNTT1,
mislinkNTT1, Fig. S1), the decrease in transport activity results neither
from an inverted orientation of NTT1 across the membrane, nor to a
problem of locked conformation due to steric hindrance. Improper
folding of NTT1 in the Mistic fusions can also be ruled out from our
experiments. Indeed, in E. coli membranes, misNTT1 retains native
binding sites for ADP and ATP as evidenced by KM determination and
the cleaved fusion recovers the activity of mature NTT1. Based on
these observations, folding and quaternary structures were further
characterized to get a better molecular understanding of NTT1/
misNTT1 differences.Fig. 3. Production and speciﬁc radioactive ATP uptake of in vivo cleaved misTevNTT1. Pane
expressed in C43(DE3) and TEV and misTevNTT1 proteolysis products expressed in BL21(
be detected as indicated on the ﬁgure. * indicates the BCCP, an endogenously biotinylated
probably corresponds to a NTT1 by-product generated during expression. 2 mg of whole ce
Panel B, speciﬁc activity for TEV alone, misTevNTT1 alone and misTevNTT1 and TEV expresse
ATP/min/mg of transporter. For TEV, no quantity of protein was taken into consideration.3.3. Analysis of overall-fold and quaternary structures of recombinant
NTT1, misNTT1 and cleaved Mistic NTT1 (clmisXaNTT1)
3.3.1. Puriﬁcation of NTT1, misNTT1 and clmisXaNTT1
In order to perform an in-depth molecular characterization of the
three proteins, NTT1, misXaNTT1 and the cleaved fusion clmisXaNTT1
have to be obtained in solution and homogeneous before biochemical/
biophysical analysis. misXaNTT1 and clmisXaNTT1 were puriﬁed
using the same overall approach as the one developed for NTT1:
LAPAO solubilization followed by Immobilized Metal Ion Afﬁnity
Chromatography (IMAC) and Strep-Tactin chromatography steps. For
the production of clmisXaNTT1, several misNTT1 constructs have
been designed to enable the cleavage of the fusion and the subsequent
puriﬁcation of NTT1 mature form after Mistic removal. For that
purpose, several speciﬁc protease cleavage sites have been introduced
and tested. Factor Xa cleavage site provided the best cleavage yields
and was therefore chosen for subsequent studies. This fusion, called
misXaNTT1, kept the same properties (production level and activity in
E. coli) as misNTT1 (not shown). The three NTT1 forms have all been
obtained with a very similar and satisfying ﬁnal purity (Fig. 4) withl A, Detection via Histag (right panel), Streptag (left panel) of both NTT1 or misNTT1
DE3). Due to its small size and low abundance Mistic required a longer exposure to
protein always detected by Strep-Tactin peroxidase in whole bacterial extracts and #
lls have been loaded per lane. MM corresponds to the molecular weight marker lanes.
d simultaneously or sequentially using 50 μM ATP. Activities are expressed in nmole of
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clmisXaNTT1, respectively, from 1 L of culture.
3.3.2. NTT1 is most probably correctly folded within misXaNTT1
The solubilization patterns of NTT1 and misXaNTT1 from E. coli
membrane using detergents having different physico-chemical proper-
ties gave ﬁrst indications of similarities or differences in the overall fold
of the two proteins. Several detergents were tested: octaethylene glycol
monododecyl ether (C12E8), β-dodecylmaltoside (DDM), β-octylgluco-
side (OG), laurylamidodimethylpropylaminoxyde (LAPAO), lauryldi-
methylaminoxyde (LDAO) and Fos-choline12 (FC12). For both NTT1
and misXaNTT1, C12E8, DDM and OG were not or poorly efﬁcient to
solubilize any protein (Fig. 5A–B), while NTT1 and misXaNTT1 were
well solubilized frommembranes by LDAO and evenmore efﬁciently by
LAPAO and FC12 (Fig. 5A–B). However, NTT1 and misXaNTT1 were
not solubilized to the same extent: while the former was almost 100%
solubilized by LAPAO, for misXaNTT1 only 30–40% of the protein can
be solubilized by this detergent (Fig. 5A–B). This limited solubilization
of misXaNTT1 was the main reason to explain the limited yield of
puriﬁedmisXaNTT1 and clmisXaNTT1 regarding the expression yield of
misXaNTT1.
The three proteins NTT1, misNTT1 and clmisXaNTT1 puriﬁed in
LAPAO were also assessed by limited proteolysis to highlight putative
compact domains [25]. Herein,misNTT1wasused insteadofmisXaNTT1
to avoid a preferred limited proteolysis site at the factor Xa cleavageFig. 5. Overall fold of NTT1, misNTT1 and clmisXaNTT1. Panel A, NTT1 from overexpressing
Tactin peroxidase western-blot. 10 μg of total membrane proteins have been loaded into e
detergents. Solubilized Mistic fusion was detected as a band at 70 kDa on Coomassie-stained
into each lane. Panels C, D and E, kinetic of NTT1 (C), misNTT1 (D) and clmisXaNTT1 (E) chy
Mistic alone with §. 5 μg of total proteolyzed protein have been loaded into each lane. M
membrane protein control.sequence. Several proteases were used: chymotrypsin (Fig. 5C–E),
trypsin and elastase (not shown), but all three gave similar results. NTT1
and clmisXaNTT1 (both indicated with *) had a very similar behavior
(Fig. 5C and E) and limited proteolysis led to a single fragment
corresponding to clmisXaNTT1. Indeed, during proteolysis, NTT1 lost its
ﬁve N-terminal residues to reach the size of the clmisXaNTT1. misNTT1
(indicated with #) was proteolysed into two stable fragments which
sizes correspond to Mistic (indicated with §) and NTT1 (Fig. 5D). The
two fragments of misNTT1 were already visible after 15 min and
misNTT1was completely cleavedwithin 120 min. Thus,misNTT1 seems
to encompass two compact and independently structured domains:
Mistic and NTT1, demonstrating that NTT1 is most probably well folded
within the fusion protein.
3.3.3. Oligomeric state of NTT1 is recovered following cleavage of
misXaNTT1
Oligomerization might be an important issue for the activity.
Therefore, the oligomeric states of NTT1, misXaNTT1 and clmis-
XaNTT1 have been assessed by SEC and analytical ultracentrifugation
(AUC). SEC elution proﬁles of NTT1 and clmisXaNTT1 were quite
similar and revealed two main species in the intermediate molecular
mass range, as well as the presence of a few other higher molecular
mass species (Fig. 6A). In contrast, misXaNTT1 had a completely
different oligomeric behavior: the protein eluted as quite a broad
peak of higher molecular mass than that of NTT1 and clmisXaNTT1membranes extracted by different detergents. Solubilized NTT1 was detected by Strep-
ach lane. Panel B, misXaNTT1 from overexpressing membranes extracted by different
SDS-PAGE, shown with the arrow. 10 μg of total membrane proteins have been loaded
motrypsinolysis between 0 and 180 min. NTT1 is indicated with *, misNTT1 with # and
corresponds to the molecular weight marker lanes and MT corresponds to the total
Fig. 6. NTT1, misXaNTT1 and clmisXaNTT1 quaternary organizations. Panel A, pure
NTT1 (long dash line), misXaNTT1 (small dash line) and clmisXaNTT1 (continuous line)
size exclusion chromatography. Panel B, pure NTT1 (long dash line), misXaNTT1 (small
dash line) and clmisXaNTT1 (continuous line) sedimentation coefﬁcient distributions
from sedimentation velocity experiments. Panel C, NTT1 (hashed bar), misXaNTT1
(squared bar) and clmisXaNTT1 (black bar) AUC species distribution analysis over three
independent experiments.
2065A. Deniaud et al. / Biochimica et Biophysica Acta 1808 (2011) 2059–2066(Fig. 6A). This difference cannot result from themass increase induced
by the fusion to Mistic (13 kDa). To assess the quaternary structure of
misXaNTT1 more precisely, AUC sedimentation velocity experiments
have been performed. NTT1 was mainly present as a 1.9 S (species 1)
and a 2.9 S (species 2) species (Fig. 6B), and clmisXaNTT1 shows a
similar species distribution (Fig. 6B). misXaNTT1 had a more
heterogeneous oligomeric content with mainly high molecular mass
species centered around 5.5 S (Fig. 6B). The results for the three
proteins were highly reproducible over different puriﬁed protein
batches. The relative proportions of species 1, species 2 and high
molecular weight species have been averaged over three independent
puriﬁcations and showed that large oligomers were twice more
present in misXaNTT1 than in NTT1 or clmisXaNTT1 (Fig. 6C).
Interestingly, our results showed that misXaNTT1 after cleavage into
clmisXaNTT1 returns to an oligomerization status identical to NTT1.
4. Conclusions
The determination of the high-resolution structure of eukaryotic
membrane transporters is hampered by difﬁculties in obtaining
protein crystals. As such, the availability of pure recombinant proteins
in relative abundance allows wide screening of crystallization
conditions and increases the likelihood of getting diffracting crystals.
Herein, we demonstrated that fusion with Mistic results in increased
level of recombinant ATP/ADP transporter production. While, the
fusion protein has a strongly affected transport activity in E. coli
membranes, in vivo fusion cleavage led to the delivery of a functional
transporter. Furthermore, molecular characterization clearly showedthat NTT1 forms an independent and well-folded transporter within
the Mistic fusion. Moreover, we have shown that the amount of
puriﬁed clmisXaNTT1 is four times higher than the quantity obtained
from the puriﬁcation of NTT1 produced as a mature protein. This
production yield could be further increased by ﬁne-tuning the
expression level and/or by co-expressing chaperones to increase the
amount of well-folded protein. Even though the use of Mistic has been
successfully reported since its initial description in the literature [8]
its mechanism of action is still not understood. However, it seems that
Mistic has the ability to pull membrane proteins into E. colimembrane
most probably via Mistic oligomers. Indeed, we showed that
oligomeric status equilibrium turns to large oligomers formed by
Mistic boundaries in misNTT1 fusion. Furthermore, the ten times
transport rate decrease in misNTT1 in comparison to NTT1 mainly
relates from this oligomeric status alteration. Indeed, Mistic multi-
mers could interfere with a proper NTT1 interface. It is therefore
important to keep in mind this Mistic polymerization effect, when
using the Mistic fusion strategy. Finally, in the case of NTT1 the low
speciﬁc activity of misNTT1 might also contribute to its strong
overexpression by reducing potential detrimental effect on E. coli
metabolism.
In conclusion, we explored expression, puriﬁcation, activity and
biochemical/biophysical properties of a chloroplast ATP/ADP trans-
porter fused toMistic. The low speciﬁc activity of theMistic-transporter
fusion did not circumvent the interest of this approach for large scale
puriﬁcation of membrane proteins. Indeed, NTT1 is properly folded and
can be delivered in a native state after fusion cleavage.
Supplementarymaterials related to this article can be found online
at doi:10.1016/j.bbamem.2011.04.011.
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